Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Axsome Therapeutics, Inc. (AXSM) had Debt to Equity Ratio of 2.17 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$196.00M |
|
$-28.56M |
|
$12.33M |
|
$183.67M |
|
$222.96M |
|
$-26.96M |
|
$-1.17M |
|
$-28.13M |
|
$-28.13M |
|
$-28.56M |
|
$-28.56M |
|
$-28.56M |
|
$-28.56M |
|
$-26.96M |
|
$-24.52M |
|
49.75M |
|
49.75M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$588.99M |
|
$0.56M |
|
$100.82M |
|
$689.80M |
|
$378.84M |
|
$121.95M |
|
$222.67M |
|
$601.51M |
|
$88.29M |
|
$35.73M |
|
$88.30M |
|
50.88M |
|
| Cash Flow Statement Financials | |
$-93.41M |
|
$-0.48M |
|
$101.47M |
|
$315.35M |
|
$322.93M |
|
$7.58M |
|
$93.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.55 |
|
-- |
|
-- |
|
0.58 |
|
|
Debt to Equity Ratio |
2.17 |
93.71% |
|
-13.75% |
|
-13.75% |
|
-- |
|
-14.35% |
|
-14.57% |
|
$-93.89M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
0.44 |
|
0.87 |
|
103.07 |
|
-32.34% |
|
-79.92% |
|
-4.14% |
|
-13.58% |
|
$1.74 |
|
$-1.89 |
|
$-1.88 |
|